Literature DB >> 26924088

Heterogeneity Among Liver Cancer--A Hurdle to Optimizing Therapy.

Nicolai Juul Birkbak1, Jesper B Andersen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26924088     DOI： 10.1053/j.gastro.2016.02.063

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  Single cell profiling reveals window for immunotherapy in liver cancers.

Authors:  Jesper B Andersen
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

2.  Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.

Authors:  Ryan A Hlady; Dan Zhou; William Puszyk; Lewis R Roberts; Chen Liu; Keith D Robertson
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

3.  Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver.

Authors:  Liping Zhong; Yong Huang; Jian He; Nuo Yang; Banghao Xu; Yun Ma; Junjie Liu; Chao Tang; Chengpiao Luo; Pan Wu; Zongqiang Lai; Yu Huo; Tao Lu; Dongni Huang; Wenlin Gong; Lu Gan; Yiqun Luo; Zhikun Zhang; Xiyu Liu; Yongxiang Zhao
Journal:  Signal Transduct Target Ther       Date:  2021-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.